{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:26:16Z","timestamp":1794036376155,"version":"4.8.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009033","name":"Center of Innovation Program","doi-asserted-by":"publisher","award":["JPMJCE1310"],"award-info":[{"award-number":["JPMJCE1310"]}],"id":[{"id":"10.13039\/501100009033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interstitial pneumonia (IP) is a collective term for diseases whose main lesion is fibrosis of the pulmonary interstitium, and the prognosis associated with acute exacerbation of these conditions is often poor. Therapeutic agents are limited to steroids, immunosuppressants, and antifibrotic drugs, which and have many side effects; therefore, the development of new therapeutic agents is required. Because oxidative stress contributes to lung fibrosis in IP, optimal antioxidants may be effective for the treatment of IP. Silicon (Si)-based agents, when administered orally, can continuously generate a large amount of antioxidant hydrogen in the intestinal tract. In this study, we investigated the effect of our Si-based agent on methotrexate-induced IP, using the IP mouse models. Pathological analysis revealed that interstitial hypertrophy was more significantly alleviated in the Si-based agent-treated group than in the untreated group (decreased by about 22%; P\u2009&lt;\u20090.01). Moreover, additional morphological analysis demonstrated that infiltration of immune cells and fibrosis in the lungs were significantly inhibited by treatment with the Si-based agent. Furthermore, Si-based agent reduced oxidative stress associated with IP by increasing blood antioxidant activity. (increased by about 43%; P\u2009&lt;\u20090.001). Taken together, these results suggest that Si-based agents can be effective therapeutic agents for IP.<\/jats:p>","DOI":"10.1038\/s41598-023-32745-8","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T10:04:44Z","timestamp":1680861884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effect of the new silicon-based agent on the symptoms of interstitial pneumonitis"],"prefix":"10.1038","volume":"13","author":[{"given":"Masato","family":"Shimada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3965-0716","authenticated-orcid":false,"given":"Yoshihisa","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"key":"32745_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis, W. D. et al. An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 188, 733\u2013748. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"32745_CR2","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1007\/s12325-019-00928-3","volume":"36","author":"I Hanta","year":"2019","unstructured":"Hanta, I., Cilli, A. & Sevinc, C. The effectiveness, safety, and tolerability of pirfenidone in idiopathic pulmonary fibrosis: A retrospective study. Adv. Ther. 36, 1126\u20131131. https:\/\/doi.org\/10.1007\/s12325-019-00928-3 (2019).","journal-title":"Adv. Ther."},{"key":"32745_CR3","first-page":"190","volume":"28","author":"S Keishi","year":"2019","unstructured":"Keishi, S. Diagnosis and treatments of interstitial pneumonia. J. Jpn. Soc. Respir. Care Rehabil. 28, 190\u2013195 (2019).","journal-title":"J. Jpn. Soc. Respir. Care Rehabil."},{"key":"32745_CR4","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.bbadis.2012.11.021","volume":"1028\u20131040","author":"P Cheresh","year":"1832","unstructured":"Cheresh, P., Kim, S. J., Tulasiram, S. & Kamp, D. W. Oxidative stress and pulmonary fibrosis. Biochim. Biophys. Acta 1028\u20131040, 2013. https:\/\/doi.org\/10.1016\/j.bbadis.2012.11.021 (1832).","journal-title":"Biochim. Biophys. Acta"},{"key":"32745_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1164\/rccm.200501-017PP","volume":"172","author":"VL Kinnula","year":"2005","unstructured":"Kinnula, V. L., Fattman, C. L., Tan, R. J. & Oury, T. D. Oxidative stress in pulmonary fibrosis: A possible role for redox modulatory therapy. Am. J. Respir. Crit. Care Med. 172, 417\u2013422. https:\/\/doi.org\/10.1164\/rccm.200501-017PP (2005).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"32745_CR6","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1183\/09031936.95.08081286","volume":"8","author":"J Behr","year":"1995","unstructured":"Behr, J. et al. Increased oxidation of extracellular glutathione by bronchoalveolar inflammatory cells in diffuse fibrosing alveolitis. Eur. Respir. J. 8, 1286\u20131292. https:\/\/doi.org\/10.1183\/09031936.95.08081286 (1995).","journal-title":"Eur. Respir. J."},{"key":"32745_CR7","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1183\/09031936.02.00204902","volume":"19","author":"J Behr","year":"2002","unstructured":"Behr, J., Degenkolb, B., Krombach, F. & Vogelmeier, C. Intracellular glutathione and bronchoalveolar cells in fibrosing alveolitis: Effects of N-acetylcysteine. Eur. Respir. J. 19, 906\u2013911. https:\/\/doi.org\/10.1183\/09031936.02.00204902 (2002).","journal-title":"Eur. Respir. J."},{"key":"32745_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1164\/ajrccm\/139.2.370","volume":"139","author":"AM Cantin","year":"1989","unstructured":"Cantin, A. M., Hubbard, R. C. & Crystal, R. G. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 139, 370\u2013372. https:\/\/doi.org\/10.1164\/ajrccm\/139.2.370 (1989).","journal-title":"Am. Rev. Respir. Dis."},{"key":"32745_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0140-6736(91)90350-x","volume":"338","author":"Z Borok","year":"1991","unstructured":"Borok, Z. et al. Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis. Lancet 338, 215\u2013216. https:\/\/doi.org\/10.1016\/0140-6736(91)90350-x (1991).","journal-title":"Lancet"},{"key":"32745_CR10","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1172\/JCI113005","volume":"79","author":"AM Cantin","year":"1987","unstructured":"Cantin, A. M., North, S. L., Fells, G. A., Hubbard, R. C. & Crystal, R. G. Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J. Clin. Invest. 79, 1665\u20131673. https:\/\/doi.org\/10.1172\/JCI113005 (1987).","journal-title":"J. Clin. Invest."},{"key":"32745_CR11","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1164\/ajrccm.158.5.9803102","volume":"158","author":"P Montuschi","year":"1998","unstructured":"Montuschi, P. et al. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am. J. Respir. Crit. Care Med. 158, 1524\u20131527. https:\/\/doi.org\/10.1164\/ajrccm.158.5.9803102 (1998).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"32745_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1465-9921-11-31","volume":"11","author":"N Kikuchi","year":"2010","unstructured":"Kikuchi, N. et al. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1\/Th2 balance. Respir. Res. 11, 31. https:\/\/doi.org\/10.1186\/1465-9921-11-31 (2010).","journal-title":"Respir. Res."},{"key":"32745_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1124\/jpet.112.194142","volume":"342","author":"X He","year":"2012","unstructured":"He, X., Wang, L., Szklarz, G., Bi, Y. & Ma, Q. Resveratrol inhibits paraquat-induced oxidative stress and fibrogenic response by activating the nuclear factor erythroid 2-related factor 2 pathway. J. Pharmacol. Exp. Ther. 342, 81\u201390. https:\/\/doi.org\/10.1124\/jpet.112.194142 (2012).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"32745_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/s0891-5849(03)00402-7","volume":"35","author":"CL Fattman","year":"2003","unstructured":"Fattman, C. L. et al. Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic. Biol. Med. 35, 763\u2013771. https:\/\/doi.org\/10.1016\/s0891-5849(03)00402-7 (2003).","journal-title":"Free Radic. Biol. Med."},{"key":"32745_CR15","doi-asserted-by":"publisher","first-page":"L846","DOI":"10.1152\/ajplung.90590.2008","volume":"297","author":"S Murthy","year":"2009","unstructured":"Murthy, S. et al. Modulation of reactive oxygen species by Rac1 or catalase prevents asbestos-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 297, L846-855. https:\/\/doi.org\/10.1152\/ajplung.90590.2008 (2009).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"32745_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/10715769109105225","volume":"15","author":"B Parizada","year":"1991","unstructured":"Parizada, B., Werber, M. M. & Nimrod, A. Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic. Res. Commun. 15, 297\u2013301. https:\/\/doi.org\/10.3109\/10715769109105225 (1991).","journal-title":"Free Radic. Res. Commun."},{"key":"32745_CR17","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1164\/ajrccm.160.4.9811060","volume":"160","author":"M Lois","year":"1999","unstructured":"Lois, M., Brown, L. A., Moss, I. M., Roman, J. & Guidot, D. M. Ethanol ingestion increases activation of matrix metalloproteinases in rat lungs during acute endotoxemia. Am. J. Respir. Crit. Care Med. 160, 1354\u20131360. https:\/\/doi.org\/10.1164\/ajrccm.160.4.9811060 (1999).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"32745_CR18","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1017\/S0007114515002597","volume":"114","author":"D Impellizzeri","year":"2015","unstructured":"Impellizzeri, D. et al. Protective effect of polyphenols in an inflammatory process associated with experimental pulmonary fibrosis in mice. Br. J. Nutr. 114, 853\u2013865. https:\/\/doi.org\/10.1017\/S0007114515002597 (2015).","journal-title":"Br. J. Nutr."},{"key":"32745_CR19","doi-asserted-by":"publisher","first-page":"921724","DOI":"10.1155\/2013\/921724","volume":"2013","author":"R Verma","year":"2013","unstructured":"Verma, R. et al. Evaluating the ameliorative potential of quercetin against the bleomycin-induced pulmonary fibrosis in Wistar rats. Pulm. Med. 2013, 921724. https:\/\/doi.org\/10.1155\/2013\/921724 (2013).","journal-title":"Pulm. Med."},{"key":"32745_CR20","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s10753-012-9491-0","volume":"35","author":"R Akgedik","year":"2012","unstructured":"Akgedik, R. et al. Effect of resveratrol on treatment of bleomycin-induced pulmonary fibrosis in rats. Inflammation 35, 1732\u20131741. https:\/\/doi.org\/10.1007\/s10753-012-9491-0 (2012).","journal-title":"Inflammation"},{"key":"32745_CR21","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.pupt.2006.07.003","volume":"20","author":"G Sener","year":"2007","unstructured":"Sener, G., Topalo\u011flu, N., Sehirli, A. O., Ercan, F. & Gedik, N. Resveratrol alleviates bleomycin-induced lung injury in rats. Pulm. Pharmacol. Ther. 20, 642\u2013649. https:\/\/doi.org\/10.1016\/j.pupt.2006.07.003 (2007).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"32745_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s11051-017-3873-z","volume":"19","author":"Y Kobayashi","year":"2017","unstructured":"Kobayashi, Y., Matsuda, S., Imamura, K. & Kobayashi, H. Hydrogen generation by reaction of Si nanopowder with neutral water. J. Nanopart. Res. 19, 176. https:\/\/doi.org\/10.1007\/s11051-017-3873-z (2017).","journal-title":"J. Nanopart. Res."},{"key":"32745_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nm1577","volume":"13","author":"I Ohsawa","year":"2007","unstructured":"Ohsawa, I. et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med. 13, 688\u2013694. https:\/\/doi.org\/10.1038\/nm1577 (2007).","journal-title":"Nat. Med."},{"key":"32745_CR24","doi-asserted-by":"publisher","first-page":"9634","DOI":"10.1038\/s41598-022-13655-7","volume":"12","author":"Y Koyama","year":"2022","unstructured":"Koyama, Y. et al. A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent. Sci. Rep. 12, 9634. https:\/\/doi.org\/10.1038\/s41598-022-13655-7 (2022).","journal-title":"Sci. Rep."},{"key":"32745_CR25","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1038\/s41598-020-62755-9","volume":"10","author":"Y Kobayashi","year":"2020","unstructured":"Kobayashi, Y. et al. Renoprotective and neuroprotective effects of enteric hydrogen generation from Si-based agent. Sci. Rep. 10, 5859. https:\/\/doi.org\/10.1038\/s41598-020-62755-9 (2020).","journal-title":"Sci. Rep."},{"key":"32745_CR26","doi-asserted-by":"publisher","first-page":"6168","DOI":"10.1038\/s41598-022-10228-6","volume":"12","author":"N Otani","year":"2022","unstructured":"Otani, N. et al. Hydrogen-generating Si-based agent protects against skin flap ischemia-reperfusion injury in rats. Sci. Rep. 12, 6168. https:\/\/doi.org\/10.1038\/s41598-022-10228-6 (2022).","journal-title":"Sci. Rep."},{"issue":"3","key":"32745_CR27","doi-asserted-by":"publisher","first-page":"665506","DOI":"10.3389\/fmedt.2021.665506","volume":"13","author":"N Usui","year":"2021","unstructured":"Usui, N. et al. Si-based hydrogen-producing nanoagent protects fetuses from miscarriage caused by mother-to-child transmission. Front. Med. Technol. 13(3), 665506. https:\/\/doi.org\/10.3389\/fmedt.2021.665506 (2021).","journal-title":"Front. Med. Technol."},{"key":"32745_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00292-020-00907-4","volume":"42","author":"I Bittmann","year":"2021","unstructured":"Bittmann, I. Drug-induced interstitial lung diseases. Pathologe 42, 11\u201316. https:\/\/doi.org\/10.1007\/s00292-020-00907-4 (2021).","journal-title":"Pathologe"},{"key":"32745_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2131\/jts.35.653","volume":"35","author":"M Ohbayashi","year":"2010","unstructured":"Ohbayashi, M. et al. Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro. J. Toxicol. Sci. 35, 653\u2013661. https:\/\/doi.org\/10.2131\/jts.35.653 (2010).","journal-title":"J. Toxicol. Sci."},{"key":"32745_CR30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/0277-5379(85)90228-7","volume":"21","author":"C Pesce","year":"1985","unstructured":"Pesce, C. et al. Pulmonary toxicity in mice after high-dose methotrexate administration with and without leucovorin rescue. Eur. J. Cancer Clin. Oncol. 21, 875\u2013880. https:\/\/doi.org\/10.1016\/0277-5379(85)90228-7 (1985).","journal-title":"Eur. J. Cancer Clin. Oncol."},{"issue":"17","key":"32745_CR31","first-page":"3334","volume":"2013","author":"S Kalemci","year":"2013","unstructured":"Kalemci, S. et al. The efficacy of minocycline against methotrexate-induced pulmonary fibrosis in mice. Eur. Rev. Med. Pharmacol. Sci. 2013(17), 3334\u20133340 (2013).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"32745_CR32","doi-asserted-by":"publisher","first-page":"30334","DOI":"10.1074\/jbc.270.51.30334","volume":"270","author":"VJ Thannickal","year":"1995","unstructured":"Thannickal, V. J. & Fanburg, B. L. Activation of an H2O2-generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. J. Biol. Chem. 270, 30334\u201330338. https:\/\/doi.org\/10.1074\/jbc.270.51.30334 (1995).","journal-title":"J. Biol. Chem."},{"key":"32745_CR33","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.1073\/pnas.84.16.5788","volume":"84","author":"SM Wahl","year":"1987","unstructured":"Wahl, S. M. et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84, 5788\u20135792. https:\/\/doi.org\/10.1073\/pnas.84.16.5788 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"32745_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.med.55.091902.103810","volume":"55","author":"VJ Thannickal","year":"2004","unstructured":"Thannickal, V. J., Toews, G. B., White, E. S., Lynch, J. P. & Martinez, F. J. Mechanisms of pulmonary fibrosis. Annu. Rev. Med. 55, 395\u2013417. https:\/\/doi.org\/10.1146\/annurev.med.55.091902.103810 (2004).","journal-title":"Annu. Rev. Med."},{"key":"32745_CR35","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1165\/ajrcmb.21.1.3379","volume":"21","author":"A Bellocq","year":"1999","unstructured":"Bellocq, A. et al. Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. Am. J. Respir. Cell Mol. Biol. 21, 128\u2013136. https:\/\/doi.org\/10.1165\/ajrcmb.21.1.3379 (1999).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"32745_CR36","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1210\/mend.10.9.8885242","volume":"10","author":"MH Barcellos-Hoff","year":"1996","unstructured":"Barcellos-Hoff, M. H. & Dix, T. A. Redox-mediated activation of latent transforming growth factor-beta 1. Mol. Endocrinol. 10, 1077\u20131083. https:\/\/doi.org\/10.1210\/mend.10.9.8885242 (1996).","journal-title":"Mol. Endocrinol."},{"key":"32745_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1165\/ajrcmb.17.5.2833","volume":"17","author":"K Arsalane","year":"1997","unstructured":"Arsalane, K. et al. Transforming growth factor-beta1 is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: Transcriptional effect on the GSH rate-limiting enzyme gamma-glutamylcysteine synthetase. Am. J. Respir. Cell Mol. Biol. 17, 599\u2013607. https:\/\/doi.org\/10.1165\/ajrcmb.17.5.2833 (1997).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"32745_CR38","doi-asserted-by":"publisher","first-page":"15846","DOI":"10.1074\/jbc.273.25.15846","volume":"273","author":"VM Factor","year":"1998","unstructured":"Factor, V. M., Kiss, A., Woitach, J. T., Wirth, P. J. & Thorgeirsson, S. S. Disruption of redox homeostasis in the transforming growth factor-alpha\/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. J. Biol. Chem. 273, 15846\u201315853. https:\/\/doi.org\/10.1074\/jbc.273.25.15846 (1998).","journal-title":"J. Biol. Chem."},{"key":"32745_CR39","doi-asserted-by":"publisher","first-page":"12384","DOI":"10.1074\/jbc.M208544200","volume":"278","author":"VJ Thannickal","year":"2003","unstructured":"Thannickal, V. J. et al. Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J. Biol. Chem. 278, 12384\u201312389. https:\/\/doi.org\/10.1074\/jbc.M208544200 (2003).","journal-title":"J. Biol. Chem."},{"key":"32745_CR40","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1164\/ajrccm.162.5.9906096","volume":"162","author":"M Suga","year":"2000","unstructured":"Suga, M. et al. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 162, 1949\u20131956. https:\/\/doi.org\/10.1164\/ajrccm.162.5.9906096 (2000).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"32745_CR41","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.freeradbiomed.2004.06.008","volume":"37","author":"KK Nelson","year":"2004","unstructured":"Nelson, K. K. & Melendez, J. A. Mitochondrial redox control of matrix metalloproteinases. Free Radic. Biol. Med. 37, 768\u2013784. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.06.008 (2004).","journal-title":"Free Radic. Biol. Med."},{"key":"32745_CR42","doi-asserted-by":"publisher","first-page":"28403","DOI":"10.1074\/jbc.M304739200","volume":"278","author":"X Fu","year":"2003","unstructured":"Fu, X., Kassim, S. Y., Parks, W. C. & Heinecke, J. W. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): An oxidative mechanism for restraining proteolytic activity during inflammation. J. Biol. Chem. 278, 28403\u201328409. https:\/\/doi.org\/10.1074\/jbc.M304739200 (2003).","journal-title":"J. Biol. Chem."},{"key":"32745_CR43","doi-asserted-by":"publisher","first-page":"7043","DOI":"10.1111\/jcmm.14603","volume":"23","author":"Y Terasaki","year":"2019","unstructured":"Terasaki, Y. et al. Effect of H2 treatment in a mouse model of rheumatoid arthritis-associated interstitial lung disease. J. Cell. Mol. Med. 23, 7043\u20137053. https:\/\/doi.org\/10.1111\/jcmm.14603 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"32745_CR44","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","volume":"8","author":"PM George","year":"2020","unstructured":"George, P. M., Wells, A. U. & Jenkins, R. G. Pulmonary fibrosis and COVID-19: The potential role for antifibrotic therapy. Lancet Respir. Med. 8, 807\u2013815. https:\/\/doi.org\/10.1016\/S2213-2600(20)30225-3 (2020).","journal-title":"Lancet Respir. Med."},{"key":"32745_CR45","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.21037\/jtd-2020-057","volume":"12","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Hydrogen\/oxygen mixed gas inhalation improves disease severity and dyspnea in patients with Coronavirus disease 2019 in a recent multicenter, open-label clinical trial. J. Thorac. Dis. 12, 3448\u20133452. https:\/\/doi.org\/10.21037\/jtd-2020-057 (2020).","journal-title":"J. Thorac. Dis."},{"key":"32745_CR46","first-page":"5","volume":"30","author":"F Takao","year":"2018","unstructured":"Takao, F. Clinical practice guideline of methotrexate for patients with rheumatoid arthritis: 2016 update version. Clin. Rheumatol. Relat. Res 30, 5\u201311 (2018).","journal-title":"Clin. Rheumatol. Relat. Res"},{"key":"32745_CR47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1538\/expanim.60.481","volume":"60","author":"S Kawai","year":"2011","unstructured":"Kawai, S., Takagi, Y., Kaneko, S. & Kurosawa, T. Effect of three types of mixed anesthetic agents alternate to ketamine in mice. Exp. Anim. 60, 481\u2013487. https:\/\/doi.org\/10.1538\/expanim.60.481 (2011).","journal-title":"Exp. Anim."},{"key":"32745_CR48","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1093\/jn\/131.12.3208","volume":"131","author":"U Cornelli","year":"2001","unstructured":"Cornelli, U., Terranova, R., Luca, S., Cornelli, M. & Alberti, A. Bioavailability and antioxidant activity of some food supplements in men and women using the d-roms test as a marker of oxidative stress. J. Nutr. 131, 3208\u20133211 (2001).","journal-title":"J. Nutr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32745-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32745-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32745-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T10:51:37Z","timestamp":1680864697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32745-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["32745"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-32745-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5707"}}